Analysts/Institutional Investor Meet/Con. Call Updates

Emcure Ref: EPL/CS/SE/0060/2026 Date: July 15, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400 051 Mumbai- 400 001 Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE Dear Sir/Madam, Subject: Intimation for Earnings Call – Q1 FY27 Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform that the Earnings Call for Investors / Analysts will be held on Thursday, August 06, 2026 at 4.00 p.m. (IST) to discuss the Company’s Unaudited Financial Results (Standalone and Consolidated) and performance for the quarter ended June 30, 2026. The details of the aforesaid earnings call for Investors/Analysts is enclosed. The transcript and the audio recording of the Earnings Call will be made available on the Company’s website i.e. www.emcure.com and will be intimated accordingly. You are requested to take the above information on your records. Thanking you, For Emcure Pharmaceuticals Limited Amruta Yangalwar Company Secretary & Compliance Officer ICSI Membership No.: A25687 Emcure Pharmaceuticals Limited Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251 Q1 FY 2026–27 Earnings Conference Call Invitation for Earnings Call The management team of Emcure Pharmaceuticals Limited will host a conference call for analysts and investors following the announcement of the Company’s financial results for the quarter ended June 30,2026. The call will be conducted via Zoom Webinar and will begin with brief remarks from the management team, followed by a question-and-answer session. Please use the registration link below to participate. CONFERENCE CALL DETAILS Date Thursday, August 6, 2026 Time 04:00 pm IST Registration CLICK HERE TO REGISTER Audio Recording Will be made available before the next trading day or within 24 hours from the end of the call, whichever is earlier. Recording Access Available on the Company website: Emcure > Investors > Financial > Earnings Call Recordings Conference Call Transcript Will be made available within 5 working days from the conclusion of the call. Transcript Access Available on the Company website: Emcure > Investors > Financial > Earnings Call Transcript Note: Participants are requested to join 10 minutes before the scheduled start time of the call. For further information / institutional investor queries Saurabh Paliwal | investor.relations@emcure.com DISCLAIMER Certain statements made during the conference call, including during the question-and-answer session, may constitute forwardlooking statements based on the current expectations, assumptions and projections of Emcure Pharmaceuticals Limited. Such statements are not guarantees of future performance and are subject to risks and uncertainties, including regulatory, productdevelopment, approval, commercialization, intellectual-property, manufacturing, supply-chain, competitive, currency and marketrelated factors—that could cause actual results to differ materially. Participants should not place undue reliance on these statements. The call is for general informational purposes only and does not constitute investment or medical advice, or an offer, solicitation or recommendation to buy, sell or subscribe to any securities of the Company. Information concerning products or indications under development or awaiting approval is subject to applicable regulatory requirements and intellectual-property rights, and availability may vary by jurisdiction. The Company undertakes no obligation to publicly update any forward-looking statement except as required under applicable law.